| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.32B | +8.8% |
| Cost of Revenue | $368.6M | +9.6% |
| Gross Profit | $949.2M | +8.4% |
| R&D Expense | $294.3M | +12.9% |
| SG&A Expense | $117.7M | +41.0% |
| Operating Income | -$109.4M | -15.5% |
| Interest Expense | $7.8M | -2.1% |
| Pre-tax Income | -$161.8M | -22.6% |
| Income Tax | $183.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.1M | -9.3% |
| Short-term Investments | $152.2M | -25.0% |
| Accounts Receivable | $255.2M | +39.6% |
| Current Assets | $846.5M | +0.7% |
| Total Assets | $1.36B | -14.8% |
| Current Liabilities | $538.9M | +11.0% |
| Total Liabilities | $1.23B | +4.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $22.3M | -42.9% |
| Capital Expenditures | $35.4M | +238.4% |
| Investing Cash Flow | $13.1M | -82.0% |
| Financing Cash Flow | -$47.0M | +61.4% |
| Free Cash Flow | -$13.0M | -145.5% |
| +366.6% |
| Net Income | -$345.6M | -448.2% |
| EPS (Basic) | -$4.22 | -448.1% |
| EPS (Diluted) | -$4.22 | -448.1% |
| Stockholders' Equity |
| $130.8M |
| -68.6% |